nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—DCK—Doxorubicin—Epirubicin—testicular cancer	0.0119	0.519	CbGdCrCtD
Emtricitabine—DCK—Epirubicin—Doxorubicin—testicular cancer	0.011	0.481	CbGdCrCtD
Emtricitabine—DCK—embryo—testicular cancer	0.00466	0.249	CbGeAlD
Emtricitabine—DCK—seminal vesicle—testicular cancer	0.00437	0.234	CbGeAlD
Emtricitabine—DCK—gonad—testicular cancer	0.00316	0.169	CbGeAlD
Emtricitabine—DCK—female gonad—testicular cancer	0.00257	0.137	CbGeAlD
Emtricitabine—DCK—testis—testicular cancer	0.00228	0.122	CbGeAlD
Emtricitabine—DCK—lymph node—testicular cancer	0.00165	0.0883	CbGeAlD
Emtricitabine—Headache—Vinblastine—testicular cancer	0.00135	0.0014	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00134	0.0014	CcSEcCtD
Emtricitabine—Abdominal pain—Dactinomycin—testicular cancer	0.00134	0.0014	CcSEcCtD
Emtricitabine—Body temperature increased—Dactinomycin—testicular cancer	0.00134	0.0014	CcSEcCtD
Emtricitabine—Fatigue—Ifosfamide—testicular cancer	0.00134	0.00139	CcSEcCtD
Emtricitabine—Hypersensitivity—Bleomycin—testicular cancer	0.00134	0.00139	CcSEcCtD
Emtricitabine—Infection—Cisplatin—testicular cancer	0.00133	0.00139	CcSEcCtD
Emtricitabine—Pain—Ifosfamide—testicular cancer	0.00133	0.00138	CcSEcCtD
Emtricitabine—Nervous system disorder—Cisplatin—testicular cancer	0.00131	0.00137	CcSEcCtD
Emtricitabine—Cough—Etoposide—testicular cancer	0.00131	0.00137	CcSEcCtD
Emtricitabine—Thrombocytopenia—Cisplatin—testicular cancer	0.00131	0.00137	CcSEcCtD
Emtricitabine—Blood creatinine increased—Epirubicin—testicular cancer	0.00131	0.00136	CcSEcCtD
Emtricitabine—Asthenia—Bleomycin—testicular cancer	0.0013	0.00136	CcSEcCtD
Emtricitabine—Skin disorder—Cisplatin—testicular cancer	0.0013	0.00135	CcSEcCtD
Emtricitabine—Pruritus—Bleomycin—testicular cancer	0.00128	0.00134	CcSEcCtD
Emtricitabine—Nausea—Vinblastine—testicular cancer	0.00128	0.00133	CcSEcCtD
Emtricitabine—Hypokalaemia—Epirubicin—testicular cancer	0.00127	0.00133	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00127	0.00132	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00127	0.00132	CcSEcCtD
Emtricitabine—Pancreatitis—Methotrexate—testicular cancer	0.00126	0.00132	CcSEcCtD
Emtricitabine—Breast disorder—Epirubicin—testicular cancer	0.00126	0.00132	CcSEcCtD
Emtricitabine—Nasopharyngitis—Epirubicin—testicular cancer	0.00125	0.0013	CcSEcCtD
Emtricitabine—Hypersensitivity—Dactinomycin—testicular cancer	0.00125	0.0013	CcSEcCtD
Emtricitabine—Muscular weakness—Epirubicin—testicular cancer	0.00123	0.00128	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.00123	0.00128	CcSEcCtD
Emtricitabine—Urticaria—Ifosfamide—testicular cancer	0.00123	0.00128	CcSEcCtD
Emtricitabine—Abdominal pain—Ifosfamide—testicular cancer	0.00123	0.00128	CcSEcCtD
Emtricitabine—Body temperature increased—Ifosfamide—testicular cancer	0.00123	0.00128	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00122	0.00127	CcSEcCtD
Emtricitabine—Infection—Etoposide—testicular cancer	0.00122	0.00127	CcSEcCtD
Emtricitabine—Asthenia—Dactinomycin—testicular cancer	0.00121	0.00127	CcSEcCtD
Emtricitabine—Blood creatinine increased—Doxorubicin—testicular cancer	0.00121	0.00126	CcSEcCtD
Emtricitabine—Neutropenia—Methotrexate—testicular cancer	0.00121	0.00126	CcSEcCtD
Emtricitabine—Paraesthesia—Cisplatin—testicular cancer	0.0012	0.00125	CcSEcCtD
Emtricitabine—Thrombocytopenia—Etoposide—testicular cancer	0.0012	0.00125	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Methotrexate—testicular cancer	0.0012	0.00125	CcSEcCtD
Emtricitabine—Dyspnoea—Cisplatin—testicular cancer	0.00119	0.00124	CcSEcCtD
Emtricitabine—Skin disorder—Etoposide—testicular cancer	0.00119	0.00124	CcSEcCtD
Emtricitabine—Pancreatitis—Epirubicin—testicular cancer	0.00118	0.00123	CcSEcCtD
Emtricitabine—Hypokalaemia—Doxorubicin—testicular cancer	0.00118	0.00123	CcSEcCtD
Emtricitabine—Breast disorder—Doxorubicin—testicular cancer	0.00117	0.00122	CcSEcCtD
Emtricitabine—Diarrhoea—Dactinomycin—testicular cancer	0.00116	0.00121	CcSEcCtD
Emtricitabine—Pneumonia—Methotrexate—testicular cancer	0.00116	0.00121	CcSEcCtD
Emtricitabine—Nasopharyngitis—Doxorubicin—testicular cancer	0.00116	0.00121	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00115	0.0012	CcSEcCtD
Emtricitabine—Vomiting—Bleomycin—testicular cancer	0.00115	0.0012	CcSEcCtD
Emtricitabine—Infestation NOS—Methotrexate—testicular cancer	0.00115	0.0012	CcSEcCtD
Emtricitabine—Infestation—Methotrexate—testicular cancer	0.00115	0.0012	CcSEcCtD
Emtricitabine—Depression—Methotrexate—testicular cancer	0.00115	0.0012	CcSEcCtD
Emtricitabine—Rash—Bleomycin—testicular cancer	0.00114	0.00119	CcSEcCtD
Emtricitabine—Pain—Cisplatin—testicular cancer	0.00114	0.00119	CcSEcCtD
Emtricitabine—Dermatitis—Bleomycin—testicular cancer	0.00114	0.00119	CcSEcCtD
Emtricitabine—Hypersensitivity—Ifosfamide—testicular cancer	0.00114	0.00119	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.00114	0.00119	CcSEcCtD
Emtricitabine—Muscular weakness—Doxorubicin—testicular cancer	0.00114	0.00119	CcSEcCtD
Emtricitabine—Renal failure—Methotrexate—testicular cancer	0.00113	0.00118	CcSEcCtD
Emtricitabine—Neutropenia—Epirubicin—testicular cancer	0.00113	0.00118	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Epirubicin—testicular cancer	0.00112	0.00117	CcSEcCtD
Emtricitabine—Asthenia—Ifosfamide—testicular cancer	0.00111	0.00116	CcSEcCtD
Emtricitabine—Paraesthesia—Etoposide—testicular cancer	0.0011	0.00115	CcSEcCtD
Emtricitabine—Pruritus—Ifosfamide—testicular cancer	0.0011	0.00114	CcSEcCtD
Emtricitabine—Haematuria—Methotrexate—testicular cancer	0.0011	0.00114	CcSEcCtD
Emtricitabine—Pancreatitis—Doxorubicin—testicular cancer	0.00109	0.00114	CcSEcCtD
Emtricitabine—Weight decreased—Epirubicin—testicular cancer	0.00109	0.00114	CcSEcCtD
Emtricitabine—Dyspnoea—Etoposide—testicular cancer	0.00109	0.00114	CcSEcCtD
Emtricitabine—Hyperglycaemia—Epirubicin—testicular cancer	0.00109	0.00114	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Methotrexate—testicular cancer	0.00109	0.00113	CcSEcCtD
Emtricitabine—Pneumonia—Epirubicin—testicular cancer	0.00108	0.00113	CcSEcCtD
Emtricitabine—Nausea—Bleomycin—testicular cancer	0.00108	0.00112	CcSEcCtD
Emtricitabine—Infestation NOS—Epirubicin—testicular cancer	0.00108	0.00112	CcSEcCtD
Emtricitabine—Infestation—Epirubicin—testicular cancer	0.00108	0.00112	CcSEcCtD
Emtricitabine—Vomiting—Dactinomycin—testicular cancer	0.00108	0.00112	CcSEcCtD
Emtricitabine—Rash—Dactinomycin—testicular cancer	0.00107	0.00111	CcSEcCtD
Emtricitabine—Diarrhoea—Ifosfamide—testicular cancer	0.00106	0.00111	CcSEcCtD
Emtricitabine—Renal failure—Epirubicin—testicular cancer	0.00106	0.0011	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Etoposide—testicular cancer	0.00106	0.0011	CcSEcCtD
Emtricitabine—Body temperature increased—Cisplatin—testicular cancer	0.00106	0.0011	CcSEcCtD
Emtricitabine—Fatigue—Etoposide—testicular cancer	0.00106	0.0011	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Epirubicin—testicular cancer	0.00105	0.0011	CcSEcCtD
Emtricitabine—Pain—Etoposide—testicular cancer	0.00105	0.00109	CcSEcCtD
Emtricitabine—Urinary tract infection—Epirubicin—testicular cancer	0.00105	0.00109	CcSEcCtD
Emtricitabine—Neutropenia—Doxorubicin—testicular cancer	0.00104	0.00109	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00104	0.00108	CcSEcCtD
Emtricitabine—Hepatitis—Methotrexate—testicular cancer	0.00103	0.00108	CcSEcCtD
Emtricitabine—Haematuria—Epirubicin—testicular cancer	0.00103	0.00107	CcSEcCtD
Emtricitabine—Dizziness—Ifosfamide—testicular cancer	0.00103	0.00107	CcSEcCtD
Emtricitabine—Pharyngitis—Methotrexate—testicular cancer	0.00102	0.00107	CcSEcCtD
Emtricitabine—Urinary tract disorder—Methotrexate—testicular cancer	0.00102	0.00106	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Epirubicin—testicular cancer	0.00102	0.00106	CcSEcCtD
Emtricitabine—Urethral disorder—Methotrexate—testicular cancer	0.00101	0.00106	CcSEcCtD
Emtricitabine—Weight decreased—Doxorubicin—testicular cancer	0.00101	0.00105	CcSEcCtD
Emtricitabine—Sinusitis—Epirubicin—testicular cancer	0.00101	0.00105	CcSEcCtD
Emtricitabine—Hyperglycaemia—Doxorubicin—testicular cancer	0.00101	0.00105	CcSEcCtD
Emtricitabine—Nausea—Dactinomycin—testicular cancer	0.001	0.00105	CcSEcCtD
Emtricitabine—Pneumonia—Doxorubicin—testicular cancer	0.001	0.00104	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Etoposide—testicular cancer	0.001	0.00104	CcSEcCtD
Emtricitabine—Infestation NOS—Doxorubicin—testicular cancer	0.000996	0.00104	CcSEcCtD
Emtricitabine—Infestation—Doxorubicin—testicular cancer	0.000996	0.00104	CcSEcCtD
Emtricitabine—Vomiting—Ifosfamide—testicular cancer	0.000986	0.00103	CcSEcCtD
Emtricitabine—Hypersensitivity—Cisplatin—testicular cancer	0.000985	0.00103	CcSEcCtD
Emtricitabine—Renal failure—Doxorubicin—testicular cancer	0.000979	0.00102	CcSEcCtD
Emtricitabine—Rash—Ifosfamide—testicular cancer	0.000977	0.00102	CcSEcCtD
Emtricitabine—Dermatitis—Ifosfamide—testicular cancer	0.000976	0.00102	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000976	0.00102	CcSEcCtD
Emtricitabine—Urticaria—Etoposide—testicular cancer	0.000973	0.00101	CcSEcCtD
Emtricitabine—Rhinitis—Epirubicin—testicular cancer	0.000968	0.00101	CcSEcCtD
Emtricitabine—Abdominal pain—Etoposide—testicular cancer	0.000968	0.00101	CcSEcCtD
Emtricitabine—Body temperature increased—Etoposide—testicular cancer	0.000968	0.00101	CcSEcCtD
Emtricitabine—Urinary tract infection—Doxorubicin—testicular cancer	0.000968	0.00101	CcSEcCtD
Emtricitabine—Hepatitis—Epirubicin—testicular cancer	0.000966	0.00101	CcSEcCtD
Emtricitabine—Asthenia—Cisplatin—testicular cancer	0.000959	0.001	CcSEcCtD
Emtricitabine—Pharyngitis—Epirubicin—testicular cancer	0.000959	0.001	CcSEcCtD
Emtricitabine—Urinary tract disorder—Epirubicin—testicular cancer	0.000954	0.000995	CcSEcCtD
Emtricitabine—Haematuria—Doxorubicin—testicular cancer	0.000949	0.000991	CcSEcCtD
Emtricitabine—Connective tissue disorder—Epirubicin—testicular cancer	0.000949	0.00099	CcSEcCtD
Emtricitabine—Urethral disorder—Epirubicin—testicular cancer	0.000947	0.000988	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000942	0.000983	CcSEcCtD
Emtricitabine—Sinusitis—Doxorubicin—testicular cancer	0.000934	0.000975	CcSEcCtD
Emtricitabine—Immune system disorder—Methotrexate—testicular cancer	0.000932	0.000973	CcSEcCtD
Emtricitabine—Mediastinal disorder—Methotrexate—testicular cancer	0.00093	0.000971	CcSEcCtD
Emtricitabine—Nausea—Ifosfamide—testicular cancer	0.000921	0.000961	CcSEcCtD
Emtricitabine—Diarrhoea—Cisplatin—testicular cancer	0.000914	0.000954	CcSEcCtD
Emtricitabine—Mental disorder—Methotrexate—testicular cancer	0.000904	0.000944	CcSEcCtD
Emtricitabine—Hypersensitivity—Etoposide—testicular cancer	0.000902	0.000941	CcSEcCtD
Emtricitabine—Malnutrition—Methotrexate—testicular cancer	0.000898	0.000938	CcSEcCtD
Emtricitabine—Rhinitis—Doxorubicin—testicular cancer	0.000896	0.000935	CcSEcCtD
Emtricitabine—Hepatitis—Doxorubicin—testicular cancer	0.000894	0.000933	CcSEcCtD
Emtricitabine—Pharyngitis—Doxorubicin—testicular cancer	0.000887	0.000926	CcSEcCtD
Emtricitabine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000883	0.000921	CcSEcCtD
Emtricitabine—Asthenia—Etoposide—testicular cancer	0.000878	0.000917	CcSEcCtD
Emtricitabine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000878	0.000916	CcSEcCtD
Emtricitabine—Urethral disorder—Doxorubicin—testicular cancer	0.000876	0.000914	CcSEcCtD
Emtricitabine—Immune system disorder—Epirubicin—testicular cancer	0.000872	0.00091	CcSEcCtD
Emtricitabine—Mediastinal disorder—Epirubicin—testicular cancer	0.000871	0.000908	CcSEcCtD
Emtricitabine—Back pain—Methotrexate—testicular cancer	0.000869	0.000907	CcSEcCtD
Emtricitabine—Pruritus—Etoposide—testicular cancer	0.000866	0.000904	CcSEcCtD
Emtricitabine—Vomiting—Cisplatin—testicular cancer	0.00085	0.000887	CcSEcCtD
Emtricitabine—Mental disorder—Epirubicin—testicular cancer	0.000846	0.000883	CcSEcCtD
Emtricitabine—Rash—Cisplatin—testicular cancer	0.000843	0.000879	CcSEcCtD
Emtricitabine—Dermatitis—Cisplatin—testicular cancer	0.000842	0.000878	CcSEcCtD
Emtricitabine—Malnutrition—Epirubicin—testicular cancer	0.000841	0.000877	CcSEcCtD
Emtricitabine—Diarrhoea—Etoposide—testicular cancer	0.000838	0.000874	CcSEcCtD
Emtricitabine—Anaemia—Methotrexate—testicular cancer	0.00083	0.000867	CcSEcCtD
Emtricitabine—Back pain—Epirubicin—testicular cancer	0.000813	0.000849	CcSEcCtD
Emtricitabine—Dizziness—Etoposide—testicular cancer	0.00081	0.000845	CcSEcCtD
Emtricitabine—Immune system disorder—Doxorubicin—testicular cancer	0.000807	0.000842	CcSEcCtD
Emtricitabine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000805	0.00084	CcSEcCtD
Emtricitabine—Nausea—Cisplatin—testicular cancer	0.000794	0.000828	CcSEcCtD
Emtricitabine—Cough—Methotrexate—testicular cancer	0.000784	0.000818	CcSEcCtD
Emtricitabine—Mental disorder—Doxorubicin—testicular cancer	0.000783	0.000817	CcSEcCtD
Emtricitabine—Vomiting—Etoposide—testicular cancer	0.000778	0.000812	CcSEcCtD
Emtricitabine—Malnutrition—Doxorubicin—testicular cancer	0.000778	0.000812	CcSEcCtD
Emtricitabine—Anaemia—Epirubicin—testicular cancer	0.000777	0.000811	CcSEcCtD
Emtricitabine—Rash—Etoposide—testicular cancer	0.000772	0.000805	CcSEcCtD
Emtricitabine—Dermatitis—Etoposide—testicular cancer	0.000771	0.000805	CcSEcCtD
Emtricitabine—Headache—Etoposide—testicular cancer	0.000767	0.0008	CcSEcCtD
Emtricitabine—Myalgia—Methotrexate—testicular cancer	0.000765	0.000798	CcSEcCtD
Emtricitabine—Arthralgia—Methotrexate—testicular cancer	0.000765	0.000798	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00076	0.000793	CcSEcCtD
Emtricitabine—Back pain—Doxorubicin—testicular cancer	0.000753	0.000785	CcSEcCtD
Emtricitabine—Cough—Epirubicin—testicular cancer	0.000734	0.000766	CcSEcCtD
Emtricitabine—Infection—Methotrexate—testicular cancer	0.000728	0.00076	CcSEcCtD
Emtricitabine—Nausea—Etoposide—testicular cancer	0.000727	0.000759	CcSEcCtD
Emtricitabine—Nervous system disorder—Methotrexate—testicular cancer	0.000719	0.00075	CcSEcCtD
Emtricitabine—Anaemia—Doxorubicin—testicular cancer	0.000719	0.00075	CcSEcCtD
Emtricitabine—Thrombocytopenia—Methotrexate—testicular cancer	0.000718	0.000749	CcSEcCtD
Emtricitabine—Arthralgia—Epirubicin—testicular cancer	0.000716	0.000747	CcSEcCtD
Emtricitabine—Myalgia—Epirubicin—testicular cancer	0.000716	0.000747	CcSEcCtD
Emtricitabine—Anxiety—Epirubicin—testicular cancer	0.000713	0.000744	CcSEcCtD
Emtricitabine—Skin disorder—Methotrexate—testicular cancer	0.000712	0.000743	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000711	0.000742	CcSEcCtD
Emtricitabine—Infection—Epirubicin—testicular cancer	0.000682	0.000711	CcSEcCtD
Emtricitabine—Cough—Doxorubicin—testicular cancer	0.000679	0.000708	CcSEcCtD
Emtricitabine—Nervous system disorder—Epirubicin—testicular cancer	0.000673	0.000702	CcSEcCtD
Emtricitabine—Thrombocytopenia—Epirubicin—testicular cancer	0.000672	0.000701	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000668	0.000697	CcSEcCtD
Emtricitabine—Skin disorder—Epirubicin—testicular cancer	0.000667	0.000696	CcSEcCtD
Emtricitabine—Insomnia—Methotrexate—testicular cancer	0.000663	0.000692	CcSEcCtD
Emtricitabine—Arthralgia—Doxorubicin—testicular cancer	0.000662	0.000691	CcSEcCtD
Emtricitabine—Myalgia—Doxorubicin—testicular cancer	0.000662	0.000691	CcSEcCtD
Emtricitabine—Anxiety—Doxorubicin—testicular cancer	0.00066	0.000689	CcSEcCtD
Emtricitabine—Paraesthesia—Methotrexate—testicular cancer	0.000658	0.000687	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000658	0.000686	CcSEcCtD
Emtricitabine—Dyspnoea—Methotrexate—testicular cancer	0.000654	0.000682	CcSEcCtD
Emtricitabine—Dyspepsia—Methotrexate—testicular cancer	0.000645	0.000674	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000633	0.000661	CcSEcCtD
Emtricitabine—Fatigue—Methotrexate—testicular cancer	0.000632	0.00066	CcSEcCtD
Emtricitabine—Infection—Doxorubicin—testicular cancer	0.000631	0.000658	CcSEcCtD
Emtricitabine—Pain—Methotrexate—testicular cancer	0.000627	0.000654	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000625	0.000652	CcSEcCtD
Emtricitabine—Nervous system disorder—Doxorubicin—testicular cancer	0.000623	0.00065	CcSEcCtD
Emtricitabine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000622	0.000649	CcSEcCtD
Emtricitabine—Insomnia—Epirubicin—testicular cancer	0.000621	0.000648	CcSEcCtD
Emtricitabine—Skin disorder—Doxorubicin—testicular cancer	0.000617	0.000644	CcSEcCtD
Emtricitabine—Paraesthesia—Epirubicin—testicular cancer	0.000616	0.000643	CcSEcCtD
Emtricitabine—Dyspnoea—Epirubicin—testicular cancer	0.000612	0.000638	CcSEcCtD
Emtricitabine—Dyspepsia—Epirubicin—testicular cancer	0.000604	0.00063	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Methotrexate—testicular cancer	0.0006	0.000626	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000592	0.000618	CcSEcCtD
Emtricitabine—Fatigue—Epirubicin—testicular cancer	0.000592	0.000617	CcSEcCtD
Emtricitabine—Pain—Epirubicin—testicular cancer	0.000587	0.000612	CcSEcCtD
Emtricitabine—Urticaria—Methotrexate—testicular cancer	0.000583	0.000608	CcSEcCtD
Emtricitabine—Abdominal pain—Methotrexate—testicular cancer	0.00058	0.000605	CcSEcCtD
Emtricitabine—Body temperature increased—Methotrexate—testicular cancer	0.00058	0.000605	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000578	0.000604	CcSEcCtD
Emtricitabine—Insomnia—Doxorubicin—testicular cancer	0.000574	0.000599	CcSEcCtD
Emtricitabine—Paraesthesia—Doxorubicin—testicular cancer	0.00057	0.000595	CcSEcCtD
Emtricitabine—Dyspnoea—Doxorubicin—testicular cancer	0.000566	0.000591	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000561	0.000586	CcSEcCtD
Emtricitabine—Dyspepsia—Doxorubicin—testicular cancer	0.000559	0.000583	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000548	0.000572	CcSEcCtD
Emtricitabine—Fatigue—Doxorubicin—testicular cancer	0.000547	0.000571	CcSEcCtD
Emtricitabine—Urticaria—Epirubicin—testicular cancer	0.000545	0.000569	CcSEcCtD
Emtricitabine—Pain—Doxorubicin—testicular cancer	0.000543	0.000567	CcSEcCtD
Emtricitabine—Body temperature increased—Epirubicin—testicular cancer	0.000542	0.000566	CcSEcCtD
Emtricitabine—Abdominal pain—Epirubicin—testicular cancer	0.000542	0.000566	CcSEcCtD
Emtricitabine—Hypersensitivity—Methotrexate—testicular cancer	0.00054	0.000564	CcSEcCtD
Emtricitabine—Asthenia—Methotrexate—testicular cancer	0.000526	0.000549	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000519	0.000542	CcSEcCtD
Emtricitabine—Pruritus—Methotrexate—testicular cancer	0.000519	0.000541	CcSEcCtD
Emtricitabine—Hypersensitivity—Epirubicin—testicular cancer	0.000506	0.000528	CcSEcCtD
Emtricitabine—Urticaria—Doxorubicin—testicular cancer	0.000504	0.000526	CcSEcCtD
Emtricitabine—Abdominal pain—Doxorubicin—testicular cancer	0.000502	0.000524	CcSEcCtD
Emtricitabine—Body temperature increased—Doxorubicin—testicular cancer	0.000502	0.000524	CcSEcCtD
Emtricitabine—Diarrhoea—Methotrexate—testicular cancer	0.000502	0.000524	CcSEcCtD
Emtricitabine—Asthenia—Epirubicin—testicular cancer	0.000492	0.000514	CcSEcCtD
Emtricitabine—Pruritus—Epirubicin—testicular cancer	0.000486	0.000507	CcSEcCtD
Emtricitabine—Dizziness—Methotrexate—testicular cancer	0.000485	0.000506	CcSEcCtD
Emtricitabine—Diarrhoea—Epirubicin—testicular cancer	0.00047	0.00049	CcSEcCtD
Emtricitabine—Hypersensitivity—Doxorubicin—testicular cancer	0.000468	0.000488	CcSEcCtD
Emtricitabine—Vomiting—Methotrexate—testicular cancer	0.000466	0.000487	CcSEcCtD
Emtricitabine—Rash—Methotrexate—testicular cancer	0.000462	0.000482	CcSEcCtD
Emtricitabine—Dermatitis—Methotrexate—testicular cancer	0.000462	0.000482	CcSEcCtD
Emtricitabine—Headache—Methotrexate—testicular cancer	0.000459	0.000479	CcSEcCtD
Emtricitabine—Asthenia—Doxorubicin—testicular cancer	0.000456	0.000475	CcSEcCtD
Emtricitabine—Dizziness—Epirubicin—testicular cancer	0.000454	0.000474	CcSEcCtD
Emtricitabine—Pruritus—Doxorubicin—testicular cancer	0.000449	0.000469	CcSEcCtD
Emtricitabine—Vomiting—Epirubicin—testicular cancer	0.000436	0.000455	CcSEcCtD
Emtricitabine—Nausea—Methotrexate—testicular cancer	0.000436	0.000455	CcSEcCtD
Emtricitabine—Diarrhoea—Doxorubicin—testicular cancer	0.000434	0.000453	CcSEcCtD
Emtricitabine—Rash—Epirubicin—testicular cancer	0.000433	0.000451	CcSEcCtD
Emtricitabine—Dermatitis—Epirubicin—testicular cancer	0.000432	0.000451	CcSEcCtD
Emtricitabine—Headache—Epirubicin—testicular cancer	0.00043	0.000449	CcSEcCtD
Emtricitabine—Dizziness—Doxorubicin—testicular cancer	0.00042	0.000438	CcSEcCtD
Emtricitabine—Nausea—Epirubicin—testicular cancer	0.000408	0.000425	CcSEcCtD
Emtricitabine—Vomiting—Doxorubicin—testicular cancer	0.000404	0.000421	CcSEcCtD
Emtricitabine—Rash—Doxorubicin—testicular cancer	0.0004	0.000418	CcSEcCtD
Emtricitabine—Dermatitis—Doxorubicin—testicular cancer	0.0004	0.000417	CcSEcCtD
Emtricitabine—Headache—Doxorubicin—testicular cancer	0.000398	0.000415	CcSEcCtD
Emtricitabine—Nausea—Doxorubicin—testicular cancer	0.000377	0.000394	CcSEcCtD
